Cyclodiode laser therapy for painful, blind glaucomatous eyes

AIMS To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes. METHODS 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain. RESULTS After a minimum fol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of ophthalmology 2001-04, Vol.85 (4), p.474-476
Hauptverfasser: Martin, Keith R G, Broadway, David C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 476
container_issue 4
container_start_page 474
container_title British journal of ophthalmology
container_volume 85
creator Martin, Keith R G
Broadway, David C
description AIMS To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes. METHODS 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain. RESULTS After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by >30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by >30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test). CONCLUSION Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of > 30% from baseline.
doi_str_mv 10.1136/bjo.85.4.474
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1723939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A75914869</galeid><sourcerecordid>A75914869</sourcerecordid><originalsourceid>FETCH-LOGICAL-b581t-87761f8c2b92c3d81c479bffea8e14d39db9ebb8157b0339f865000d60d0c9c43</originalsourceid><addsrcrecordid>eNp9kd9rFDEQx4Mo9nr65rMsCPrSPTO72fx4qFAOf5WiQrWvIclmrzmzmzPZLd5_b8od1ypFhhCS-fCd-c4g9ALwAqCmb_U6LHizIAvCyCM0A0J5WWEmHqMZxpiVABSO0HFK6_ysKLCn6AigogQInqHT5db40LrQ2sKrZGMxXtuoNtuiC7HYKDd0kz8ptHdDW6y8mkzo1RimVNitTc_Qk075ZJ_v7zn68eH99-Wn8uLrx8_Ls4tSNxzGkjNGoeOm0qIydcvBECZ011nFLZC2Fq0WVmsODdO4rkXHaZObbSlusRGG1HP0bqe7mXRvW2OHMSovN9H1Km5lUE7-nRnctVyFGwmsqkWOOXq9F4jh12TTKHuXjPVeDTabkYwKQYE0GXz1D7gOUxyyuazFRD6cskyd7KiV8lbmGYVc1azskEfnw2A7l7_PWCOAcHpbvXwAz9Ha3pmH-L28iSGlaLuDU8DydukyL13yRhKZl57xl_encwfvt3zPlEpG-S6qwbh04ARk8-yuS5dG-_uQVfGnzFnWyC9XS4mvzpvLb-eXkmf-zY7X_fr_Df4BjzfPvg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779177867</pqid></control><display><type>article</type><title>Cyclodiode laser therapy for painful, blind glaucomatous eyes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Martin, Keith R G ; Broadway, David C</creator><creatorcontrib>Martin, Keith R G ; Broadway, David C</creatorcontrib><description>AIMS To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes. METHODS 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain. RESULTS After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by &gt;30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by &gt;30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test). CONCLUSION Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of &gt; 30% from baseline.</description><identifier>ISSN: 0007-1161</identifier><identifier>EISSN: 1468-2079</identifier><identifier>DOI: 10.1136/bjo.85.4.474</identifier><identifier>PMID: 11264140</identifier><identifier>CODEN: BJOPAL</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd</publisher><subject>Aged ; Biological and medical sciences ; Blindness - etiology ; Blindness - surgery ; Care and treatment ; Confidence Intervals ; cyclodiode laser ; Glaucoma ; Glaucoma - complications ; Glaucoma - surgery ; Health aspects ; Humans ; Laser Therapy - methods ; Lasers ; Linear Models ; Longitudinal Studies ; Medical sciences ; Pain - etiology ; Pain - surgery ; Pain management ; Pain Measurement ; painful blind eyes ; Postoperative Complications ; Prospective Studies ; Scientific Correspondence ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the eye and orbit ; Tonometry, Ocular ; Treatment Outcome</subject><ispartof>British journal of ophthalmology, 2001-04, Vol.85 (4), p.474-476</ispartof><rights>British Journal of Ophthalmology</rights><rights>2001 INIST-CNRS</rights><rights>COPYRIGHT 2001 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2001 British Journal of Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b581t-87761f8c2b92c3d81c479bffea8e14d39db9ebb8157b0339f865000d60d0c9c43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1723939/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1723939/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=919967$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11264140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martin, Keith R G</creatorcontrib><creatorcontrib>Broadway, David C</creatorcontrib><title>Cyclodiode laser therapy for painful, blind glaucomatous eyes</title><title>British journal of ophthalmology</title><addtitle>Br J Ophthalmol</addtitle><description>AIMS To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes. METHODS 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain. RESULTS After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by &gt;30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by &gt;30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test). CONCLUSION Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of &gt; 30% from baseline.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blindness - etiology</subject><subject>Blindness - surgery</subject><subject>Care and treatment</subject><subject>Confidence Intervals</subject><subject>cyclodiode laser</subject><subject>Glaucoma</subject><subject>Glaucoma - complications</subject><subject>Glaucoma - surgery</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Laser Therapy - methods</subject><subject>Lasers</subject><subject>Linear Models</subject><subject>Longitudinal Studies</subject><subject>Medical sciences</subject><subject>Pain - etiology</subject><subject>Pain - surgery</subject><subject>Pain management</subject><subject>Pain Measurement</subject><subject>painful blind eyes</subject><subject>Postoperative Complications</subject><subject>Prospective Studies</subject><subject>Scientific Correspondence</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the eye and orbit</subject><subject>Tonometry, Ocular</subject><subject>Treatment Outcome</subject><issn>0007-1161</issn><issn>1468-2079</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kd9rFDEQx4Mo9nr65rMsCPrSPTO72fx4qFAOf5WiQrWvIclmrzmzmzPZLd5_b8od1ypFhhCS-fCd-c4g9ALwAqCmb_U6LHizIAvCyCM0A0J5WWEmHqMZxpiVABSO0HFK6_ysKLCn6AigogQInqHT5db40LrQ2sKrZGMxXtuoNtuiC7HYKDd0kz8ptHdDW6y8mkzo1RimVNitTc_Qk075ZJ_v7zn68eH99-Wn8uLrx8_Ls4tSNxzGkjNGoeOm0qIydcvBECZ011nFLZC2Fq0WVmsODdO4rkXHaZObbSlusRGG1HP0bqe7mXRvW2OHMSovN9H1Km5lUE7-nRnctVyFGwmsqkWOOXq9F4jh12TTKHuXjPVeDTabkYwKQYE0GXz1D7gOUxyyuazFRD6cskyd7KiV8lbmGYVc1azskEfnw2A7l7_PWCOAcHpbvXwAz9Ha3pmH-L28iSGlaLuDU8DydukyL13yRhKZl57xl_encwfvt3zPlEpG-S6qwbh04ARk8-yuS5dG-_uQVfGnzFnWyC9XS4mvzpvLb-eXkmf-zY7X_fr_Df4BjzfPvg</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Martin, Keith R G</creator><creator>Broadway, David C</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010401</creationdate><title>Cyclodiode laser therapy for painful, blind glaucomatous eyes</title><author>Martin, Keith R G ; Broadway, David C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b581t-87761f8c2b92c3d81c479bffea8e14d39db9ebb8157b0339f865000d60d0c9c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blindness - etiology</topic><topic>Blindness - surgery</topic><topic>Care and treatment</topic><topic>Confidence Intervals</topic><topic>cyclodiode laser</topic><topic>Glaucoma</topic><topic>Glaucoma - complications</topic><topic>Glaucoma - surgery</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Laser Therapy - methods</topic><topic>Lasers</topic><topic>Linear Models</topic><topic>Longitudinal Studies</topic><topic>Medical sciences</topic><topic>Pain - etiology</topic><topic>Pain - surgery</topic><topic>Pain management</topic><topic>Pain Measurement</topic><topic>painful blind eyes</topic><topic>Postoperative Complications</topic><topic>Prospective Studies</topic><topic>Scientific Correspondence</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the eye and orbit</topic><topic>Tonometry, Ocular</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martin, Keith R G</creatorcontrib><creatorcontrib>Broadway, David C</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martin, Keith R G</au><au>Broadway, David C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclodiode laser therapy for painful, blind glaucomatous eyes</atitle><jtitle>British journal of ophthalmology</jtitle><addtitle>Br J Ophthalmol</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>85</volume><issue>4</issue><spage>474</spage><epage>476</epage><pages>474-476</pages><issn>0007-1161</issn><eissn>1468-2079</eissn><coden>BJOPAL</coden><abstract>AIMS To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes. METHODS 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain. RESULTS After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by &gt;30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by &gt;30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test). CONCLUSION Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of &gt; 30% from baseline.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group Ltd</pub><pmid>11264140</pmid><doi>10.1136/bjo.85.4.474</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1161
ispartof British journal of ophthalmology, 2001-04, Vol.85 (4), p.474-476
issn 0007-1161
1468-2079
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1723939
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Aged
Biological and medical sciences
Blindness - etiology
Blindness - surgery
Care and treatment
Confidence Intervals
cyclodiode laser
Glaucoma
Glaucoma - complications
Glaucoma - surgery
Health aspects
Humans
Laser Therapy - methods
Lasers
Linear Models
Longitudinal Studies
Medical sciences
Pain - etiology
Pain - surgery
Pain management
Pain Measurement
painful blind eyes
Postoperative Complications
Prospective Studies
Scientific Correspondence
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the eye and orbit
Tonometry, Ocular
Treatment Outcome
title Cyclodiode laser therapy for painful, blind glaucomatous eyes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T11%3A46%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclodiode%20laser%20therapy%20for%20painful,%20blind%20glaucomatous%20eyes&rft.jtitle=British%20journal%20of%20ophthalmology&rft.au=Martin,%20Keith%20R%20G&rft.date=2001-04-01&rft.volume=85&rft.issue=4&rft.spage=474&rft.epage=476&rft.pages=474-476&rft.issn=0007-1161&rft.eissn=1468-2079&rft.coden=BJOPAL&rft_id=info:doi/10.1136/bjo.85.4.474&rft_dat=%3Cgale_pubme%3EA75914869%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779177867&rft_id=info:pmid/11264140&rft_galeid=A75914869&rfr_iscdi=true